| Models Name |
Cat.No. |
Animal Type |
Disease Area |
|
Diffuse large B-cell lymphoma, patient-derived xenograft (LY3071 (rituximab-resistant)), in SCID mouse (CB17)
|
AB93971 |
mouse |
Lymphoma,diffuse large B-cell |
|
Diffuse large B-cell lymphoma, xenograft (HBL2), in SCID mouse (CB17)
|
AB93972 |
mouse |
Lymphoma,diffuse large B-cell |
|
Diffuse large B-cell lymphoma, xenograft (OCI-Ly10), in SCID mouse (CB17)
|
AB93973 |
mouse |
Lymphoma,diffuse large B-cell |
|
Diffuse large B-cell lymphoma, xenograft (OCI-Ly19), in SCID mouse (CB17)
|
AB93974 |
mouse |
Lymphoma,diffuse large B-cell |
|
Diffuse large B-cell lymphoma, xenograft (OCI-Ly3), in SCID mouse (CB17)
|
AB93975 |
mouse |
Lymphoma,diffuse large B-cell |
|
Diffuse large B-cell lymphoma, xenograft (OCI-Ly7), in SCID mouse (CB17)
|
AB93976 |
mouse |
Lymphoma,diffuse large B-cell |
|
Diffuse large B-cell lymphoma, xenograft (OCI-Ly9 transfected with luciferase), in SCID mouse (CB17)
|
AB93977 |
mouse |
Lymphoma,diffuse large B-cell |
|
Diffuse large B-cell lymphoma, xenograft (Pfeiffer), in SCID mouse (CB17)
|
AB93978 |
mouse |
Lymphoma,diffuse large B-cell |
|
Diminished ovarian reserve, cyclophosphamide-induced, in mouse (Swiss albino)
|
AB93982 |
mouse |
Diminished ovarian reserve |
|
DNA Methyltransferase I (DNMT1) inhibition, xenograft (MM1S), in SCID mouse (CB17)
|
AB93983 |
mouse |
|